Koninklijke DSM (OTCMKTS:RDSMY) will be releasing its earnings data before the market opens on Thursday, February 14th. Analysts expect Koninklijke DSM to post earnings of $0.32 per share for the quarter.
Shares of Koninklijke DSM stock opened at $23.73 on Tuesday. The company has a quick ratio of 1.67, a current ratio of 2.51 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $17.22 billion, a PE ratio of 21.38, a PEG ratio of 2.60 and a beta of 1.40. Koninklijke DSM has a 1-year low of $19.45 and a 1-year high of $27.34.
RDSMY has been the topic of a number of research analyst reports. Goldman Sachs Group upgraded Koninklijke DSM from a “neutral” rating to a “buy” rating in a research report on Friday, February 1st. ValuEngine upgraded Koninklijke DSM from a “sell” rating to a “hold” rating in a research report on Wednesday, January 2nd. Macquarie initiated coverage on Koninklijke DSM in a research report on Thursday, November 29th. They issued an “outperform” rating on the stock. Finally, Zacks Investment Research downgraded Koninklijke DSM from a “hold” rating to a “sell” rating in a research report on Saturday, November 3rd.
Koninklijke DSM Company Profile
Koninklijke DSM N.V., a science-based company, engages in health, nutrition, and materials businesses worldwide. The company operates through three segments: Nutrition, Materials, and Innovation Center. The Nutrition segment offers nutrients, such as vitamins, carotenoids, nutritional lipids, and other ingredients to feed, food, pharmaceutical, and personal care industries; and food enzymes, cultures, yeast extracts, savory flavors, hydrocolloids, and other specialty ingredients for use in dairy, baking, beverage, and savory applications.
Read More: How to Use a Moving Average for Trading
Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.